Presented on Wednesday, October 12, 2022

What's new for people with ATM, CHEK2 or PALB2 mutations? by Tuya Pal, MD; Marc Tischkowitz, MD, PhD

Learn about the cancer risks associated with an ATM, CHEK2 or PALB2 mutation and the risk-management options for people with an inherited mutation in one of these genes.

Conference 2022

Annual Conference Logo